Hypotrichosis of Eyelashes

• FDA approval · 2022-12-20
  FDA Approved: BIMATOPROST — Supplemental Application (Alembic Pharmaceuticals Inc.)

  FDA has approved a supplemental application for BIMATOPROST from Alembic Pharmaceuticals Inc., representing a supplemental approval for the …

• FDA label_change · 2020-09-29
  FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for LATISSE (bimatoprost) by Allergan, updating the labeling to reflect its approved use for eyelash…

• FDA approval · 2013-01-31
  FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for LATISSE (bimatoprost) by Allergan, Inc. This action updates the product labeling.

• FDA approval · 2012-03-29
  FDA Approved: LATISSE — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for LATISSE (bimatoprost) by Allergan, Inc., related to eyelash growth labeling/indication.